Literature DB >> 26318277

Diabetes and chronic kidney disease.

Andrew Kowalski, Armand Krikorian, Edgar V Lerma.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 26318277     DOI: 10.1016/j.disamonth.2015.07.002

Source DB:  PubMed          Journal:  Dis Mon        ISSN: 0011-5029            Impact factor:   3.800


× No keyword cloud information.
  4 in total

1.  Association Between Change in Serum Aminotransferase and Mortality: A Nationwide Cohort Study in Korea.

Authors:  Hyejin Lee; Dong Wook Shin; Tae Hoon Lee; Hyung-Kook Yang; Eunmi Ahn; Jae-Moon Yoon; Hyun-Ki Lee; Beomseok Suh; Ki Young Son; Jun Suk Kim; BeLong Cho
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

Review 2.  Serotonin and Its Receptor as a New Antioxidant Therapeutic Target for Diabetic Kidney Disease.

Authors:  Yu Yang; Hui Huang; Zheng Xu; Jun-Kai Duan
Journal:  J Diabetes Res       Date:  2017-08-08       Impact factor: 4.011

3.  Trigonelline reverses high glucose-induced proliferation, fibrosis of mesangial cells via modulation of Wnt signaling pathway.

Authors:  Chen Chen; Yan Shi; Jiulong Ma; Zhen Chen; Ming Zhang; Yan Zhao
Journal:  Diabetol Metab Syndr       Date:  2022-02-09       Impact factor: 3.320

4.  Dapagliflozin reverses the imbalance of T helper 17 and T regulatory cells by inhibiting SGK1 in a mouse model of diabetic kidney disease.

Authors:  Dan Wang; Zikun Zhang; Zekun Si; Yanlin Yang; Shuangshuang Li; Yaoming Xue
Journal:  FEBS Open Bio       Date:  2021-05-01       Impact factor: 2.693

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.